We Are LC Sciences
- Headquarters in Houston, Texas – USA
- Offices/Labs in USA & China
- Representatives in Europe, Japan, Korea, & India
- Customers in > 40 countries
- First microRNA microarray service provider (since 2005)
- Leading position in customer publications in peer reviewed journals
What We Do
Our Latests Successes
The OligoMix® technology has significantly reduced the cost and increased the speed of highly multiplexing genome-scale experiments such as exploration of small RNAs and designer gene/DNA library synthesis. OligoMix® technology has been applied to library construction of various biomolecules, sequence capture for targeted next-gen sequencing, and synthetic biology. The recently developed OligoFix™ strategy for error correction of microarray synthesized oligos has greatly improved the utility of OligoMix® for synthetic biology applications.
LC Sciences has developed the underlying technologies for a targeted sequencing system engineered to accomplish all the required steps for accurate NGS testing (target selection, library preparation and molecular tagging) in a simple one-step workflow, the simplest workflow among all competing technologies which require a minimum of 2-4 hands-on steps. Made possible by the novel and patent pending Relay-PCR™ and Omega-Primer™ technologies, the VariantPro™ targeted sequencing system offers cost-effective, minimal hands-on, ultra-high resolution sequence analysis that enables accurate detection of rare variants.
For 12 years now, we have been providing researchers with access to innovative technologies that are enabling significant genomics and proteomics discoveries. In addition to basic research, these technologies are being applied in the areas of environmental science, agricultural research, bio-defense, forensics, clinical diagnostics, and drug development. The flexibility and power of these technologies has enabled LC Sciences to deliver a strong value proposition, including a rich product line that continues to grow and diversify, serving these rapidly advancing markets.